Citadel Advisors’s Shattuck Labs STTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,200
Closed -$4.19K 15360
2024
Q3
$4.19K Sell
1,200
-7,500
-86% -$28K ﹤0.01% 13591
2024
Q2
$33.6K Sell
8,700
-8,000
-48% -$65K ﹤0.01% 12159
2024
Q1
$149K Buy
16,700
+2,300
+16% +$21.1K ﹤0.01% 10767
2023
Q4
$103K Buy
14,400
+13,900
+2,780% +$37.9K ﹤0.01% 10903
2023
Q3
$760 Buy
+500
New +$1.14K ﹤0.01% 13989

Other funds holding STTK

Citadel Advisors's STTK Position: Q1 2026 in Review

Citadel Advisors increased its Shattuck Labs (STTK) stake by 115% in Q1 2026, buying an estimated $376K and bringing the position to 148,021 shares worth $952K. The position accounts for ﹤0.01% of the portfolio, ranked #7770.

Citadel Advisors first reported a position in STTK in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.52M in Q4 2021. 84 funds tracked by Wall St. Rank hold STTK as of Q1 2026.

  • Citadel Advisors held 148,021 shares of Shattuck Labs worth $952K as of Q1 2026.
  • Citadel Advisors bought 79,175 Shattuck Labs shares in Q1 2026, an estimated $376K.
  • Shattuck Labs made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7770 holding.
  • Citadel Advisors first reported a position in Shattuck Labs in Q3 2021 and has held it in 14 quarters since.
  • Citadel Advisors's Shattuck Labs position peaked at $1.52M in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Shattuck Labs as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.